Mediola Ismajli

Suggest Changes
Learn More
Patients with rheumatic disorders treated with TNF inhibitors are at increased risk of developing TB. There is no ‘gold-standard’ for the diagnosis of latent TB prior to initiation of biologic(More)
  • 1